Press release - 2012 first-quarter revenues
Bezons, April 11th, 2012; 5:45pm
2012 first-quarter revenues up 8%
Bezons, April 11th, 2012 - 5:45pm - RIBER, the global leader for molecular beam epitaxy (MBE), recorded €6.2 million in revenues for the first quarter of 2012, up 8% in relation to the first quarter of 2011. At the end of March 2012, the order book represented €19.5 million.
| At March 31st (€'000,000) | 2012 | 2011 | Change |
| Systems | 4.6 | 2.1 | 117% |
| Services and accessories | 1.0 | 1.0 | 1% |
| Cells and sources | 0.6 | 2.6 | -76% |
| Total reported revenues | 6.2 | 5.7 | 8% |
| Systems order book | 17.9 | 14.0 | 28% |
| Services and accessories order book | 1.5 | 2.3 | -33% |
| Cells and sources order book | 0.1 | 5.0 | -98% |
| Total order book | 19.5 | 21.3 | -8% |
Business is benefiting from the development of system sales, with three research machines and one production machine invoiced during the first quarter of 2012, compared with two research machines for the same period the previous year.
As expected, sales of evaporation sources and cells are down compared with the first quarter of 2011, which included the delivery of a major order for OLED production cells.
For services and accessories, revenues show a positive trend, climbing 1% in relation to the first quarter of 2011. The commercial action plan rolled out since the start of the year is expected to pave the way for growth in sales over 2012.
Outlook
During the period, RIBER booked four MBE system orders for research laboratories in Belgium, Argentina, Russia and the US. At March 31st, 2012, the order book came to €19.5 million, with 13 research systems to be delivered in 2012 and 2013, as well as one production machine.
The contraction in the order book for cells and sources factors in the delivery of a major investment order during the last 12 months for OLED production equipment. RIBER is focusing on preparing a new generation range of cells with a view to the next waves of investments.
RIBER will be releasing its revenue forecasts for 2012 at the end of the first half of this year.
Next date: General Meeting on Wednesday May 30th, 2012
| About RIBER: Riber designs and produces molecular beam epitaxy (MBE) systems as well as evaporation sources and cells for the semiconductor industry. This high-tech equipment is essential for the manufacturing of compound semiconductor materials and new materials that are used in numerous consumer applications, from new information technologies to OLED flat screens and new generation solar cells. Riber is listed on Euronext Paris Compartment "C" and is part of the CAC Small, CAC Mid & Small and CAC IT indexes. ISIN: FR0000075954 Reuters code: RIBE.PA Bloomberg code: RIB: FP Riber has been innovation certified by OSEO, the dedicated French innovation agency, enabling it to qualify for French innovation mutual funds (FCPI). |
| RIBER Olivier Handschumacher tel: +33 1 39 96 65 00 invest@riber.com | CALYPTUS Cyril Combe tel: +33 1 53 65 68 68 cyril.combe@calyptus.net |
